Loss of autoreceptor functions in mice lacking the dopamine transporter

Nature Neuroscience

Volumn 2, Issue 7, 1999, Pages 649-655

  Jones, Sara R ^a   Gainetdinov, Raul R ^a   Hu, Xiu Ti ^b   Cooper, Donald C ^b   Wightman, R Mark ^c   White, Francis J ^b   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORECEPTOR; DOPAMINE TRANSPORTER;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; GENE DELETION; MALE; MENTAL DISEASE; MOUSE; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; AUTORADIOGRAPHY; BRAIN; CARRIER PROTEINS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTRIC STIMULATION; FEEDBACK; GENE DELETION; HOMOVANILLIC ACID; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRODIALYSIS; NERVE TISSUE PROTEINS; NEURONS; QUINPIROLE; RECEPTORS, DOPAMINE D2; SALICYLAMIDES;

EID: 0033360080     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/10204     Document Type: Article

References (41)

1. Elsworth, J. D. & Roth, R. H. in The Dopamine Receptors (eds. Neve, K. A. & Neve, R. L.) 223-265 (Humana, Totowa, New Jersey, 1997).
2. Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L. & Schwanz, J.-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146-151 (1990).
3. Gainetdinov, R. R., Grekhova, T. V., Sotnikova, T. D. & Rayevsky, K. S. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats. Eur. J. Pharmacol. 261, 327-331 (1994).
4. Tepper, J. M., Sun, B.-C., Martin, L. P. & Creese, I. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neurosci. 17, 2519-2530 (1997).
5. Mercuri, N. B. et al. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 79, 323-327 (1997).
6. Koeltzow, T. E. et al. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J. Neurosci. 18, 2231-2238 (1998).
7. Bannon, M. J. & Roth, R. H. Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev. 35, 53-68 (1983).
8. Cragg, S. J. & Greenfield, S. A. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area and striatum. J. Neurosci. 17, 5738-5746 (1997).
9. Bates, M. D. et al. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. Mol. Pharmacol. 39, 55-63 (1990).
10. Drukarch, B., Schepens, E. & Stoof, J. C. Sustained activation does not desensitize the dopamine D2 receptor-mediated control of evoked in vitro release of radiolabeled acetylcholine from rat striatum. Eur. J. Pharmacol. 196, 209-212 (1991).
11. Ivins, K. J., Luedtke, R. R., Artymyshyn, R. P. & Molinoff, P. B. Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol. Pharmacol. 39, 531-539 (1991).
12. van Muiswinkel, F. L., Drukarch, B., Steinbusch, H. W. & Stoof, J. C. Dopamine D2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: Implications for the combined pharmaco-and grafting therapy in Parkinsonian patients. Exp. Neurol. 125, 218-227 (1994).
13. Pitts, D. K., Wang, L., Kelland, M. D., Freeman, A. S. & Chiodo, L. A. Repeated stimulation of dopamine D2-like receptors: Reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole. J. Pharmacol. Exp. Ther. 275, 412-421 (1995).
14. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612 (1996).
15. Jones, S. R. et al. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. 95, 4029-4034 (1998).
16. Kalivas, P. W. & White, F. J. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51, 141-153 (1998).
17. Cook, E. H. et al. Association of attention deficit hyperactivity disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56, 993-998 (1995).
18. Gill, M., Daly, G., Heron, S., Hawi, Z. & Fitzgerald, M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol. Psychiatry 2, 311-313 (1997).
19. Waldman, I. D. et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63, 1767-1776 (1998).
20. Gainetdinov, R. R. et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397-401 (1999).
21. Timmerman, W., De Vries, J. B. & Westerink, B. H. Effects of D2 agonists on the release of dopamine: localization of the mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 342, 650-660 (1990).
22. White, F. J. & Wang, R. Y. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci. 32, 983-993 (1983).
23. Walters, J. R. & Roth, R. H. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmied. Arch. Pharmacol. 296, 5-14 (1976).
24. Westerink, B. H, De Vries, J. B. & Duran, R. Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats. J. Neurochem. 54, 381-387 (1990).
25. Kennedy, R. T., Jones, S. R. & Wightman, R. M. Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J. Neurochem. 59, 449-455 (1992).
26. Drukarch, B. & Stoof, J. C. D2 dopamine autoreceptor selective drugs: do they really exist? Life Sci. 47, 361-376 (1990).
27. White, F. J. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu. Rev. Neurosci. 19, 405-436 (1996).
28. Zoli, M. et al. The emergence of the volume transmission concept. Brain Res. Brain Res. Rev. 26, 136-147 (1998).
29. Ferguson, S. S., Barak, L. S., Zhang, J. & Caron, M. G. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 74, 1095-1110 (1996).
30. Sterne-Marr, R. & Benovic, J. L. Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam. Horm. 51, 193-234 (1995).
31. Woolverton, W. L. & Johnson, K. M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13, 193-200 (1992).
32. Henry, D. J., Hu, X.-T. & White, F. J. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacohgy (Berl.) 140, 233-242 (1998).
33. Bosse, R. et al. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19, 127-138 (1997).
34. Boyson, S. J., McGonigle, P. & Molinoff, P. Quantitative autoradiographic localization of the D-1 and D-2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6, 3177-3188 (1986).
35. Burris, K. D. et al. Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology 12, 335-345 (1995).
36. Gainetdinov, R. R., Fumagalli, F., Jones, S. R. & Caron, M. G. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J. Neurochem. 69, 1322-1325 (1997).
37. Franklin, K. B. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego, 1997).
38. White, F. J., Hu, X.-T., Zhang, X.-F. & Wolf, M. E. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol. Exp. Ther. 273, 445-454 (1995).
39. Xu, M. et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor deficient mice. Cell 79, 945-955 (1994).
40. Kawagoe, K., Zimmerman, J. B. & Wightman, R. M. Principles of voltammetry and microelectrode surface states. J. Neurosci. Methods 48, 225-240 (1993).
41. 41. Jones, S. R., Garris, P. A., Kilts, C. D. & Wightman, R. M. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen and nucleus accumbens. J. Neurochem. 64, 2581-2589 (1995).